Benzinga's Weekend M&A Chatter

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday March 13 through Sunday March 15, 2015: Conflicting Reports on Potential Whiting Sale The Rumor:
Shares of Whiting Petroleum CHTR spiked sharply higher Friday, and were halted on a circuit-breaker, on a report from Bloomberg that the company has drawn interest from potential buyers, including ExxonMobil XOM, Continental Resources Inc CLR, Hess HES and Statoil STO, according to sources. Reuters later reported that their sources said that Whiting was selling Texas acreage and pipeline assets as an alternative to a sale of the full company. Representatives for Whiting and Hess declined comment, while Exxon, Continental and Statoil did not immediately respond. The Wall Street Journal reported on March 7, that Whiting was seeking a buyer. There was unusual activity in the March $39 Whiting call on Friday morning. Whiting Petroleum shares closed at $40.00 Friday and traded as high as $41.37 after-hours. KKR, Varde, Deutsche Bank Acquire GE Capital Consumer Finance Unit for $6.3B The Deal:
A consortium Värde Partners, KKR DB and Deutsche Bank DB have signed an agreement to acquire GE Capital's Australia and New Zealand Consumer Lending Business at an enterprise value of A$ 8.2 billion ($6.3 billion). The transaction is subject to customary regulatory approvals. Further terms of the deal were not disclosed. GE shares fell $0.36 Friday, closing at $25.04. Valeant Reportedly to Raise Bid for Salix to $160+/Share The Offer:
Valeant Pharmaceuticals International VRX is planning to raise its bid for Salix Pharmaceuticals Ltd. SLXP to more than $160 per share, according to sources, as reported by the NY Times. Pershing Square Capital Management, ValueAct Capital and Valeant will team up to raise the offer for Valeant, the sources indicated. Valeant had agreed to acquire Salix for $158 a share in cash in February. Endo International plc ENDP countered on March 11, with a bid of $175 per share, mostly in Endo shares. Pershing Square's Bill Ackman stated on Friday that Valeant would not overpay for Salix. Pershing Square reported a 5% stake in Valeant on March 9. Salix shares lost $0.65 Friday, closing at $169.40; Valeant shares gained 2.5%. to close at $197.43; Endo lost 3.5%, closing at $87.33. CRT Capital Acquires Sterne Agee's Institutional Equities Business The Deal:
Stifel Financial Corp. SF and Sterne Agee Group, Inc. announced Sunday, that they have agreed to sell Sterne Agee's Institutional Equities business, including Equity Sales, Trading and Research to CRT Capital Group LLC. Financial terms were not disclosed. Stifel Financial shares fell $0.61 Friday, closing at $55.62.